Why AbbVie Stock Cruised to an Almost 6% Gain Today

The announcement of a new buildout, as well as developments on the political front, were the factors driving up AbbVie (NYSE: ABBV) stock on Wednesday. The pharmaceutical company's shares rose by nearly 6% in value as a result, during a session when the S&P 500 (SNPINDEX: ^GSPC) crept up a comparatively modest 0.3%. On Tuesday afternoon, AbbVie reported that it had begun construction on a $70 million expansion of its AbbVie Bioresearch Center (ABC) in the Massachusetts city of Worcester. The project is aimed at bolstering both research and development (R&D) of investigational medicines and manufacturing, specifically of biologics. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool